Prices delayed by at least 15 minutes | Print

Live UK pricing:

Scancell Holdings PLC (SCLP)

ORD 0.1P
Sell: 9.50p|Buy: 10.00p|Change: 0 (0%)

Not yet a customer?

Low cost dealing from £1.50

Choose from our range of SIPP, ISA and Dealing accounts

Find out more

Open 

9.75p


Previous close 

9.75p


Trade high 

10.20p


Volume 

99,189


Year high 

18.00p


Year low 

7.26p


Dividend yield 


Market capitalisation 

£101.18 mn


P/E ratio 


ISIN 

GB00B63D3314


Share price

Performance 15/10/2025

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Scancell Holdings PLC+ 2.63
FTSE AIM All Share- 0.27
More...

Company profile

Scancell Holdings PLC is a clinical-stage biotechnology company developing targeted off-the-shelf active immunotherapies to generate safe and long-lasting tumour-specific immunity for a cancer-free future. iSCIB1+, a product from its DNA ImmunoBody platform (AvidiMab), has demonstrated safe, durable, and clinically meaningful benefit as a monotherapy as well as additional benefit when combined with checkpoint therapies in an ongoing Phase 2 trial in melanoma. Modi-1, the peptide immunotherapy from its Moditope platform, is being investigated in a Phase 2 study in a broad range of solid tumours. In addition, the company has established a subsidiary with the intention to hold and develop an early-stage pipeline of high-affinity GlyMab antibodies targeting tumour-specific glycans.

Sector 

Healthcare


News

Recent trades

DateTimePriceQuantityValue (£)
16/10/202503:31:349.68150,0004,840.50
16/10/202503:13:589.921,512149.99
16/10/202502:37:149.924,043401.07
16/10/202502:23:319.6747145.55
16/10/202502:15:539.921,00899.99

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.